FISA Reauthorization: Balancing Security & Privacy

0:00It's April 7th. This is Hartford News today, your AI-powered local news. Section 702 of Pfizer is back in the spotlight, facing reauthorization by April 20th. This law lets the government target non-US persons abroad for foreign intel without warrants, pulling in phone calls, emails, and messages from providers like telecoms. The catch? It often scoops up Americans' data too, sparking forth amendment fights over privacy. The programs roots go back to 2008, overseeing yearly by a special court. Last year, Congress renewed it for two years with some tweaks, and most of Connecticut's delegation backed it, though Senator Split. Rep Jim Himes topped them on the House Intel Committee, calls it vital for presidential briefings, and warns letting it lapse, risks national security big. Time. Folks are fired up this round. Progressives in Congress demand major reforms, or no vote, and Connecticut's rep Rosa Deloro is still mulling her stance, balancing security,

1:01and citizen rights. Trump flipped from yelling, kill FISA on social media to backing it now, matching Biden's old push. But Himes says the current White House is, dragging its feet. New pushes include bills for warrants on Americans' incidental data and blocking data broker buys by feds. Critics like state AGs say it's time to curb overreach. With Congress back from recess soon, the House faces slim margins. GOP needs near unity or dem help for a two-thirds suspension vote. Himes stays open to smart fixes tied directly to the program's work, but with funding fights and election heat, big changes look slim. Lawmakers got days to thread this needle before the clock really ticks down.